Delivery Order SPE2DB24D1021-SPE2DB24FERZY
Award Date
6/7/24
Potential Completion Date
6/10/24
Potential Value
$17K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,449.90 firm fixed-price delivery order is for the product Atovaquone-Proguanil 250-100 100s, with an ultimate completion date of October 17, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of Atovaquone-Proguanil 250-100 100s, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $2,227.72 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a completion date of February 20, 2025 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the delivery of ATOVAQUONE-PROGUANIL 250-100 100S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,455.09 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, and is set to be completed by November 27, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,683.35 firm fixed-price delivery order is for the supply of 4,566,384 units of the pharmaceutical product Atovaquone-Proguanil 250-100 100s. The contract has an ultimate completion date of November 12, 2024 and was awarded on November 8, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $73,404 for the supply of Atovaquone-Proguanil 250-100 100s medication. The award is part of a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical...
This federal contract award is for the delivery of Atovaquone-Proguanil 250-100 medication to the Defense Logistics Agency (DLA). The $1,002.18 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, and does not have a set-aside designation. Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 2025. This IDC serves as the primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,707.42 Firm Fixed Price Delivery Order is for the supply of 4566369418 - ATOVAQUONE-PROGUANIL 250-100 100S, a pharmaceutical product. The award has an ultimate completion date of November 8, 2024. This contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,411.24 Firm Fixed Price Delivery Order is for the supply of ATOVAQUONE-PROGUANIL 250-100 100S, a pharmaceutical product. The contract has an ultimate completion date of May 21, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award is for the delivery of Atovaquone-Proguanil 250-100 UD 24S pharmaceutical products to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The award is a firm fixed price delivery order worth $4,224.13, with a completion date of February 7, 2024. Amerisourcebergen Drug Corp is the...
This federal contract award was issued by the Medical Supply Chain, a component of the Defense Logistics Agency (DLA), to AmerisourceBergen Drug Corp's Corporate Office division. The $1,163.28 firm fixed-price delivery order is for the supply of 4,565,863,722 units of the pharmaceutical product Atovaquone-Proguanil 250-100 100s. The contract has an ultimate completion date of September 19, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the...